PLASMAPP CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,425 KRW | -3.58% |
|
-6.55% | -40.85% |
| Apr. 21 | Plasmapp Co., Ltd. announced that it expects to receive KRW 4.5 billion in funding | CI |
| 2023 | AdaptivEndo and Plasmapp Collaborate to Develop Sterilization Techniques for Flexible Endoscopy | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 13.31B 9.71M | Sales 2023 | 12.92B 9.43M | Capitalization | 79.58B 58.1M |
|---|---|---|---|---|---|
| Net income 2022 | -17.68B -12.91M | Net income 2023 | -18.79B -13.72M | EV / Sales 2022 | 8.67 x |
| Net Debt 2022 | 14.36B 10.48M | Net Debt 2023 | 11.78B 8.6M | EV / Sales 2023 | 7.07 x |
| P/E ratio 2022 |
-5.21
x | P/E ratio 2023 |
-4.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 77.58% |
More Fundamentals
* Assessed data
More news
| 1 day | -3.58% | ||
| 1 week | -6.55% | ||
| Current month | +1.68% | ||
| 1 month | -2.41% | ||
| 3 months | -12.30% | ||
| 6 months | -43.67% | ||
| Current year | -40.85% |
1 week
2 400.00
2 585.00
1 month
2 300.002 905.00
Current year
2 300.004 360.00
1 year
2 300.007 250.00
3 years
2 300.009 150.00
5 years
2 300.009 150.00
10 years
2 300.009 150.00
| Managers | Title | Age | Since |
|---|---|---|---|
Youbong Lim
CEO | Chief Executive Officer | - | 14-12-31 |
Hong Sun Lee
DFI | Director of Finance/CFO | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-13 | 2,425 | -3.58% | 96,525 |
| 24-05-10 | 2,515 | 0.00% | 41,278 |
| 24-05-09 | 2,515 | -1.37% | 52,222 |
| 24-05-08 | 2,550 | 0.00% | 32,881 |
End-of-day quote Korea S.E., May 12, 2024
More quotes
Plasmapp Co Ltd is a Korea-based company mainly engaged in the provision of medical solutions. The Company is engaged in the provision of low temperature plasma sterilization solutions, implant regeneration and activation solutions. The Company is also engaged in the manufacture and sale of medical devices. The Company's products include sterilizers, sterile consumables, regenerative activators, consumables, accessories and others.
Calendar
2024-08-11
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -40.85% | 37.16M | |
| +73.37% | 12.41B | |
| -18.59% | 8.23B | |
| -0.90% | 6.46B | |
| +15.76% | 5.5B | |
| -4.95% | 5.33B | |
| +40.80% | 5.1B | |
| -17.52% | 4.05B | |
| -29.79% | 2.54B | |
| +7.56% | 1.99B |
- Stock Market
- Equities
- A405000 Stock
